Error loading player: No playable sources found
240
Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment
Date
October 1, 2022
Free
Standard Price
Sponsored by Urovant Sciences
Speakers
Diane K. Newman, DNP, FAAN, BCB-PMD
Professor and Co-Director of the Penn Center for Continence and Pelvic Health, Perelman School of Medicine, University of Pennsylvania
Julie F. Buesser, MSN, AGPCNP
Urology Nurse Practitioner, UroPartners
Related Products
Narcotic-Free ERAS Protocol for Outpatient Robotic-Assisted Laparoscopic Prostatectomies /// Closing Remarks
The development, application, and results of a narcotic-free enhanced recovery after surgery (ERAS) protocol specific for our ambulatory surgery center performing robotic-assisted laparoscopic prostatectomies (RALP) is discussed…
Childhood Sexual Abuse (CSA) - Implications for the Pediatric Urology Patient and It's Long-Term Effects into Adulthood
Childhood sexual abuse (CSA) is a situation far more prevalent than most people realize. It crosses all socio-economic lines and has significant implications for pediatric urological conditions…
Focal Therapy for Prostate Cancer
Focal therapy of prostate cancer is becoming an increasingly popular treatment of localized disease aimed at minimizing the detrimental impact on quality of life…
Fad Diets, Exercise, OTC Pills, and Vaccines from A to Z: What is New in 2022!
The latest quality control (QC) options when considering recommending products over the counter (OTC) is discussed. Clinical studies supporting and not supporting these options for prostate cancer prevention, treatment, and side effects is reviewed…
